Eye movement desensitization and reprocessing for depression: a systematic review and meta-analysis
Sara Carletto1, Francesca Malandrone2, Paola Berchialla2
1Department of Neurosciences, University of Turin, Turin, Italy.
European Journal of Psychotraumatology
|April 23, 2021
Summary
Eye Movement Desensitization and Reprocessing (EMDR) shows significant efficacy in treating depression, comparable to other active therapies. Further research is needed to confirm long-term effects and relapse prevention for this mental health condition.
Area of Science:
- Psychiatry
- Psychotherapy
- Mental Health Research
Background:
- Eye Movement Desensitization and Reprocessing (EMDR) is increasingly explored for conditions beyond PTSD, including depression.
- Existing research on EMDR for depression lacks a comprehensive quantitative synthesis.
- This study addresses the need for a meta-analysis on EMDR's efficacy in treating depression.
Purpose of the Study:
- To conduct a systematic review and meta-analysis of studies evaluating EMDR for depression as a primary treatment.
- To quantitatively synthesize the available evidence on EMDR's effectiveness in reducing depressive symptoms.
Main Methods:
- Searched six major electronic databases for controlled studies on EMDR for depression.
- Included 11 studies for qualitative synthesis and 9 studies (373 participants) for meta-analysis.
- Assessed overall effect size, heterogeneity, number needed to treat, and effects at follow-up and compared to active controls.
Main Results:
- A large overall effect size (Hedges' g = -1.07) was found for EMDR in reducing depressive symptoms, despite high heterogeneity.
- Moderate and significant effects were observed at 3-6 month follow-up (g = -0.62) and compared to active controls (g = -0.68).
- No publication bias was detected, but study quality and quantity were limitations.
Conclusions:
- EMDR appears to be an effective treatment for improving depression symptoms, with outcomes comparable to other active treatments.
- Findings should be interpreted cautiously due to the limited number and methodological quality of included studies.
- Further research is recommended to explore long-term effects and relapse prevention in EMDR for depression.
Related Concept Videos
Electroconvulsive Therapy
356
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
356
Depression: Overview
517
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
517
Cognitive Therapy
592
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
592
Desensitization and Tachyphylaxis
2.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.6K
Depressive Disorders: Etiology
228
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
228
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
893
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
893


